Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
148
datasets available to search
ShareScore release 0.9.0
Dataset results
148 results for “vemurafenib”
An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol
ClinicalTrials.gov study NCT01739764. IPD Sharing: NO. Countries: 25. Publications: 0.
A Pharmacokinetics Study to Investigate the Effect of Vemurafenib on Digoxin in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma
ClinicalTrials.gov study NCT01765569. IPD Sharing: Not stated. Countries: 5. Publications: 0.
A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)
ClinicalTrials.gov study NCT06561360. IPD Sharing: YES. Countries: 1. Publications: 0.
Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E
ClinicalTrials.gov study NCT01586195. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Vemurafenib in Metastatic Melanoma Participants With Brain Metastases
ClinicalTrials.gov study NCT01378975. IPD Sharing: Not stated. Countries: 10. Publications: 0.
Vemurafenib Plus Cobimetinib After Radiosurgery in Patients With BRAF-mutant Melanoma Brain Metastases
ClinicalTrials.gov study NCT03430947. IPD Sharing: YES. Countries: 1. Publications: 0.
Selumetinib and Akt Inhibitor MK2206 in Treating Patients With Stage III or Stage IV Melanoma Who Failed Prior Therapy With Vemurafenib or Dabrafenib
ClinicalTrials.gov study NCT01519427. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effects of Treatment With Vemurafenib on the Immune System in Advanced Melanoma
ClinicalTrials.gov study NCT01942993. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study of Neoadjuvant Vemurafenib in Melanoma Patients With Untreated Brain Metastases
ClinicalTrials.gov study NCT01781026. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neddylation Signaling Inactivation by Tetracaine Hydrochloride Suppresses Cell Proliferation and Vemurafenib-resistance of Melanoma
GEO Series GSE273497. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
LINC01198 activates Hippo signaling to stimulate IL-1β autocrine for enhancing vemurafenib resistance in melanoma by associating with TAOK1/2
GEO Series GSE289512. Homo sapiens. 4 samples. Type: Expression profiling by high throughput sequencing.
FOXD1 Promotes Dedifferentiation and Vemurafenib-resistance in Melanoma by Regulating the Expression of CTGF
GEO Series GSE162973. Homo sapiens. 14 samples. Type: Expression profiling by array.
Vemurafenib induces a noncanonical senescence-associated secretory phenotype in melanoma cells which promotes vemurafenib resistance
GEO Series GSE209769. Homo sapiens. 9 samples. Type: Expression profiling by high throughput sequencing.
Melanoma GEMM Tumors, untreated or vemurafenib treated [bulk RNA-seq]
GEO Series GSE205251. Mus musculus. 34 samples. Type: Expression profiling by high throughput sequencing.
Gene expression of the A375 melanoma cell line treated with RAF inhibitors Vemurafenib and time-course with EGF stimulation during Vemurafenib RAF inhibitor treatment alone or with the MEK inhibitor
GEO Series GSE127988. Homo sapiens. 96 samples. Type: Expression profiling by high throughput sequencing.
M249 melanoma cells: Vemurafenib and Selumetinib resistant through BRAF double minutes vs. parental
GEO Series GSE153526. Homo sapiens. 2 samples. Type: Genome variation profiling by array.
Next Generation Sequencing of human BRAF melanoma cell lines treated with vemurafenib for 20 days
GEO Series GSE152699. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.
Melanoma GEMM Tumors, untreated or vemurafenib treated (scRNASeq)
GEO Series GSE126714. Mus musculus. 3 samples. Type: Expression profiling by high throughput sequencing.
Gene expression signature of vemurafenib resistance in WM989 and WM983B melanoma cells
GEO Series GSE97681. Homo sapiens. 122 samples. Type: Expression profiling by high throughput sequencing.
Profiling melanoma cell line M14 treated with vemurafenib
GEO Series GSE134838. Homo sapiens. 2 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.